CVS HEALTH Corp: directors' dealings · United States · SEC (Form 4)

About CVS HEALTH Corp

CVS Health Corp. (NYSE: CVS) is one of the largest integrated health care companies in the United States. Its business model is built around three complementary pillars: retail pharmacy and consumer wellness, pharmacy benefit management through CVS Caremark, and health insurance/medical services, primarily through Aetna. The company’s origins date back to 1963, when the first Consumer Value Store was founded in Lowell, Massachusetts. Since then, CVS has evolved from a health-and-beauty retailer into a broad health platform spanning pharmacy, benefits, insurance, and care delivery. Its corporate headquarters are in Woonsocket, Rhode Island. For European investors, CVS Health stands out as a nationally scaled, defensive health care franchise with significant operating reach. The company operates roughly 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care clinics, a leading PBM serving about 87 million plan members, and a senior-focused pharmacy care business. It also serves more than 37 million people through traditional, voluntary, and consumer-directed health insurance products. This diversification gives CVS multiple revenue streams across a highly recurring, regulated industry, while also creating potential cross-selling and care-coordination synergies between dispensing, insurance, and clinical services. From a competitive standpoint, CVS benefits from a dense distribution footprint and a powerful consumer brand, but it also faces meaningful industry headwinds. These include reimbursement pressure, changing pharmacy economics, intense competition in retail pharmacy, and rising medical-cost trends in the insurance segment. The company has been reshaping its portfolio to strengthen integrated care, including the 2023 acquisitions of Signify Health and Oak Street Health. In 2025, CVS also completed the acquisition of select Rite Aid assets, further reinforcing its pharmacy presence and market coverage. These moves support a strategy centered on broader access to care and tighter coordination across the health care journey, although execution and integration remain important watch items. Recent company developments have highlighted both progress and complexity. CVS reported quarterly results in 2025 and 2026 while emphasizing operational execution and a more connected health strategy. At the same time, the company has dealt with litigation-related charges and some pressure in parts of its care-delivery portfolio. CVS is now positioning itself around a more integrated ecosystem that links Aetna, CVS Pharmacy, CVS Caremark, and Health Care Delivery. For investors, the stock offers exposure to U.S. health care consumption, insurance, and pharmacy services, listed on the NYSE in the United States, with the usual large-cap stability of a major healthcare platform but also with integration and profitability risks that deserve close monitoring.